Suleyman Yazici
Overview
Explore the profile of Suleyman Yazici including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ezelsoy M, Bayram M, Yazici S, Yazicioglu N, Sagbas E
Cardiovasc J Afr
. 2017 Mar;
28(1):19-22.
PMID: 28262910
Objective: Cardiac resynchronisation therapy has been shown to be an effective treatment to improve functional status and prolong survival of patients in advanced chronic heart failure. This study assessed the...
2.
Caliskan A, Karahan O, Yazici S, Demirtas S, Guclu O, Tezcan O, et al.
Cardiovasc J Afr
. 2015 Dec;
26(6):222-6.
PMID: 26659436
Objective: Ginseng is a traditional herbal medicinal product widely used for various types of diseases because of its cellular protective effects. Possible protective effects of ginseng were investigated in blood,...
3.
Demirtas S, Karahan O, Yazici S, Guclu O, Caliskan A, Tezcan O, et al.
Kaohsiung J Med Sci
. 2015 Mar;
31(3):115-22.
PMID: 25744233
The aim of this study was to investigate whether anticoagulant and antiaggregant agents have protective effects against oxidative damage induced by peripheral ischemia-reperfusion (I/R). Groups were created as follows: control...
4.
Yazici S, Karahan O, Oral M, Bayramoglu Z, Unal M, Caynak B, et al.
Clin Appl Thromb Hemost
. 2015 Feb;
22(4):361-5.
PMID: 25681331
Objective: The susceptibility of tissue to ischemia-reperfusion (I/R) injury is a major obstacle to tissue regeneration and cellular survival. In this study, we investigated the possible renoprotective effect of dabigatran...
5.
Yavuz C, Callskan A, Karahan O, Demirtas S, Yazici S, Guclu O, et al.
J Pak Med Assoc
. 2014 Sep;
64(6):660-3.
PMID: 25252485
Objective: To identify the degree of vasoplegic affinity of papaverine to rat thoracic aortas following constriction caused by adrenalin, serotonin and potassium chloride in an in-vitro model. Methods: The in...
6.
Demirtas S, Karahan O, Yazici S, Guclu O, Caliskan A, Tezcan O, et al.
Cardiovasc J Afr
. 2014 Jun;
25(5):200-3.
PMID: 24967686
Objective: Mesenteric arteries release C-type natriuretic peptide (CNP), which hyperpolarises vascular smooth muscle. We measured the levels of this peptide after inducing mesenteric ischaemia over a series of time intervals,...
7.
Guclu O, Caliskan A, Karahan O, Demirtas S, Yazici S, Yavuz C, et al.
Iran J Basic Med Sci
. 2014 Jun;
17(5):318-21.
PMID: 24967059
Objectives: Biochemical markers are important for the timely diagnosis and follow-up of ischemic events. Most of the markers have been previously studied in the context of cardiac ischemia. However, research...
8.
Demirtas S, Karahan O, Yazici S, Guclu O, Caliskan A, Yavuz C, et al.
Vascular
. 2014 Feb;
22(6):427-31.
PMID: 24522438
Objective: The aim of the present study is to evaluate whether blood count parameters differ according to the stages of Fontaine's classification and to investigate the relationship between hemogram parameters...
9.
Yavuz C, Caliskan A, Karahan O, Yazici S, Guclu O, Demirtas S, et al.
Blood Coagul Fibrinolysis
. 2013 Nov;
25(4):303-8.
PMID: 24256628
Antithrombotic agents play important roles in the prophylactic and therapeutic management of many cardiovascular disorders. Therefore, many researchers have focused on developing new strategies for anticoagulation. New oral anticoagulants and...
10.
Caliskan A, Yavuz C, Karahan O, Yazici S, Guclu O, Demirtas S, et al.
J Thromb Thrombolysis
. 2013 Nov;
37(4):464-8.
PMID: 24218342
Factor-Xa inhibitors are often used for prophylaxis and for the treatment of thrombotic vascular disorders. However, it is not known whether they are beneficial during the recanalization of the thrombotic...